Changing patterns of SARS-CoV-2 seroprevalence among Canadian blood donors during the vaccine era
Changing patterns of SARS-CoV-2 seroprevalence among Canadian blood donors during the vaccine era
Simple item page
Full item details
- creativework.keywords - en
- SARS-CoV-2
- seroprevalence
- Canada
- blood donors
- dc.contributor.author
- Reedman, Cassandra N.
- Drews, Steven J.
- Yi, Qi-Long
- Pambrun, Chantale
- O'Brien, Sheila F.
- dc.date.accessioned
- 2024-01-12T18:54:26Z
- dc.date.available
- 2024-01-12T18:54:26Z
- dc.date.issued
- 2022-04-12
- dc.description.abstract - en
- We monitored the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (anti-N; proxy of natural infection) and spike protein (anti-S; proxy for humoral immunity) antibodies in blood donors across Canada from January to November 2021. The first and second doses of vaccine were deployed over this time. Anti-N seroprevalence remained low overall (about 5% or lower) from January to November but was higher in racialized groups, younger age groups, and those living in materially deprived neighborhoods. Anti-S seroprevalence corresponded with the roll out of vaccines across the country, increasing in April in older donors and then progressively to younger age groups consistent with vaccination policies targeting oldest to youngest. By November, close to 100% of blood donors were positive for anti-S. Anti-S concentrations peaked by July and began waning by September to November particularly in older donors. These data have informed national and provincial public health policy in Canada throughout vaccination rollout.
- dc.description.sponsorship
- This work was supported by funding from the Government of Canada through the COVID-19 Immunity Task Force.
- dc.identifier.citation
- 1.Reedman CN, Drews SJ, Yi QL, Pambrun C, O’Brien SF. Changing Patterns of SARS-CoV-2 Seroprevalence among Canadian Blood Donors during the Vaccine Era. Realegeno S, ed. Microbiology Spectrum. 2022;10(2). doi:https://doi.org/10.1128/spectrum.00339-22
- dc.identifier.doi
- https://doi.org/10.1128/spectrum.00339-22
- dc.identifier.issn
- 2165-0497
- dc.identifier.pubmedID
- 35412385
- dc.identifier.uri
- https://open-science.canada.ca/handle/123456789/1763
- dc.language.iso
- en
- dc.publisher
- American Society for Microbiology
- dc.rights - en
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights - fr
- Creative Commons Attribution 4.0 International (CC BY 4.0)
- dc.rights.openaccesslevel - en
- Gold
- dc.rights.openaccesslevel - fr
- Or
- dc.rights.uri - en
- https://creativecommons.org/licenses/by/4.0/
- dc.rights.uri - fr
- https://creativecommons.org/licenses/by/4.0/deed.fr
- dc.subject - en
- Health
- dc.subject - fr
- Santé
- dc.subject.en - en
- Health
- dc.subject.fr - fr
- Santé
- dc.title - en
- Changing patterns of SARS-CoV-2 seroprevalence among Canadian blood donors during the vaccine era
- dc.type - en
- Article
- dc.type - fr
- Article
- local.article.journalissue
- 2
- local.article.journaltitle
- Microbiology Spectrum
- local.article.journalvolume
- 10
- local.pagination
- 1-10
- local.peerreview - en
- Yes
- local.peerreview - fr
- Oui
Download(s)
Original bundle
1 - 1 of 1
Name: reedman-changing-patterns-of-sars-cov-2-seroprevalence.pdf
Size: 1.11 MB
Format: PDF
Collection(s)